Quantitative PCR (qPCR) Market Growth Opportunities and Forecast by 2031

The quantitative PCR (qPCR) market size is projected to reach US$ 4.82 billion by 2031 from US$ 2.57 billion in 2023; the market is estimated to record a CAGR of 8.2% during 2023–2031.

qPCR, also known as real-time PCR, allows users to monitor the progress of a PCR in real time. Employing qPCR allows professionals to calculate PCR amplification simultaneously as the reaction proceeds. qPCR is an extensively used diagnostic technique in diverse sectors such as research, pharmaceuticals, and biotechnology. The demand for molecular testing is fueled by technological advancements in PCR systems, and the need for accurate and reliable cancer biomarker detection processes. Technological advancements in qPCR technologies and the growing demand for qPCR in infectious disease diagnosis are further projected to propel the growth of the market in the coming years. The quantitative PCR (qPCR) market trends include the integration of artificial intelligence and data analysis.

Growth Drivers:

PCR has become a crucial tool for various clinical and diagnostic applications or examinations. Relative simplicity, exquisite sensitivity, and cost-effectiveness are among the noteworthy advantages of PCR that have tremendously increased the use of PCR technology in the past years. It is a robust and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and single nucleotide variation analysis. It also serves as the basis for most next-generation sequencing (NGS) preparation. Technological advancements are producing different types of PCR techniques. In particular, high-tech real-time PCR or qPCR systems are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Since its development, qPCR has grown to be an essential component of molecular biology and is widely used in research, clinical diagnostics, and testing for food safety. Its major advantages are rooted in the quantification and viral strain genotyping abilities it offers to users, enabling the estimation of reinfection based on the quantity of virus present in target tissues. It has transformed the field of nucleic acid detection and quantification, allowing researchers and medical professionals to analyze genes, mutations, and genetic variants in unprecedented detail.

CRISPR-based qPCR, automated qPCR systems, multiplex qPCR, and next-generation qPCR are examples of recent advancements in qPCR technology. With improved sensitivity, specificity, and accuracy, these systems broaden the application of qPCR in clinical diagnosis, research, and food safety testing, among other applications. Multiple target sequences can be detected and quantified in a single reaction using multiplex qPCR, saving time and reducing sample requirements. This method is useful for pathogen detection, gene expression profiling, and genetic variation analysis. In addition, next-generation qPCR helps detect and quantify nucleic acid sequences in an array of samples using cutting-edge sequencing technologies. This technique has a high degree of sensitivity and accuracy for detecting low-abundance target sequences. With careful consideration of primer design, optimization, and sample preparation, qPCR analysis can yield valuable insights into gene expression, disease diagnosis, and food safety testing. Thus, technological advancements in PCR technologies are contributing to the quantitative PCR (qPCR) market growth.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Quantitative PCR (qPCR) Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Report Segmentation and Scope:

The quantitative PCR (qPCR) market analysis has been carried out by considering the following segments: type, product, application, end user, and geography. Based on type, the market is segmented into one-step qPCR and two-step qPCR. In terms of product, the market is classified into reagents and consumables, instruments, and software and services. By application, the market is segmented into research, clinical, and forensics. Based on end user, the market is categorized into hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, forensic laboratories, and clinical research organizations. The geographic scope of the quantitative PCR (qPCR) market report covers North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Segmental Analysis:

The quantitative PCR (qPCR) market, by type, is categorized into one-step qPCR and two-step qPCR. The two-step qPCR segment held a significant market share in 2023. It is anticipated to record a higher CAGR in the market during 2023–2031.

Based on product, the market is categorized into reagents and consumables, instruments, and software and services. The reagents and consumables segment held a significant quantitative PCR (qPCR) market share in 2023, and it is further estimated to register the highest CAGR during 2023–2031.

The quantitative PCR (qPCR) market, by application, is categorized into research, clinical, and forensics. The clinical segment held a significant market share in 2023. It is anticipated to record the highest CAGR in the market during 2023–2031.

Based on end user, the quantitative PCR (qPCR) market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held a significant market share in 2023 and is expected to register the highest CAGR during 2023–2031.

Regional Analysis:

In terms of geography, the quantitative PCR (qPCR) market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2023, North America captured a significant share of the market. In 2023, the US dominated the market in this region. The quantitative PCR (qPCR) market growth in North America is attributed to the extensive R&D conducted across various academic and research institutes, growing focus on employing advanced techniques and tools in healthcare, government and private initiatives and funds for promoting precision medicine as well as genomic research, upsurge in demand for innovative products from PCR companies, and presence of key market players.

In June 2020, Azure Biosystems launched Azure Cielo real-time PCR instrument. The Cielo is a 96-well qPCR machine that maintains the brand promise of compact design, high performance, and intuitive workflow. The Azure Biosystem's sensitivity and reliability have been devoted to genomics applications. The Cielo marks the first instrument dedicated to the genomics workflow for the company.

Industry Developments and Future Opportunities:

The quantitative PCR (qPCR) market report includes company positioning and concentration to evaluate the performance of competitors in the market. As per company press releases, below are a few initiatives taken by key players operating in the market:

• In May 2023, Standard BioTools Inc. launched NGS library preparation functionality on the X9 High-Throughput Genomics System. With this launch, customers can run real-time PCR and NGS library preparation applications on a single benchtop system to support discovery through screening.
• In March 2021, Agilent Technologies Inc introduced a real-time reverse transcription (qRT) PCR-based diagnostic kit for SARS-CoV-2 RNA detection. The Agilent SARS-CoV-2 qRT-PCR Dx kit is an in vitro diagnostic reagent kit for detecting SARS-CoV-2 RNA using qRT-PCR. The single-tube assay enables increased efficiency, higher throughput, less consumable usage, and unambiguous results for testing outcomes confidence.

Quantitative PCR (qPCR) Market Regional Insights

The regional trends and factors influencing the Quantitative PCR (qPCR) Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Quantitative PCR (qPCR) Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Quantitative PCR (qPCR) Market Report Scope

Quantitative PCR (qPCR) Market Players Density: Understanding Its Impact on Business Dynamics

The Quantitative PCR (qPCR) Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Quantitative PCR (qPCR) Market are:

1. Abbott Laboratories
2. Thermo Fisher Scientific Inc.
3. Standard Biotools Inc.
4. F. Hoffmann-la Roche Ltd
5. Qiagen
6. Lepu Medical Technology Beijing Co Ltd

Disclaimer: The companies listed above are not ranked in any particular order.

Competitive Landscape and Key Companies:

The quantitative PCR (qPCR) market forecast can help stakeholders plan their growth strategies. Abbott Laboratories, Thermo Fisher Scientific Inc., Standard Biotools Inc., F. Hoffmann-la Roche Ltd, Qiagen, Lepu Medical Technology Beijing Co Ltd, Bio-rad Laboratories Inc., Takara Bio Inc., Agilent Technologies Inc., and Fujirebio are among the prominent players profiled in the market. These companies focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.